To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Sagard Healthcare Partners provides $40m loan to Valeo Pharma
The proceeds of the loan will fund the acquisition of Canadian rights to three growing commercial stage drugs.
